Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medicago Inc.

Division of Mitsubishi Chemical Holdings Corp.

Latest From Medicago Inc.

Pipeline Watch: Phase III Progress With Esaxerenone, Lusutrombopag

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

MTP Building US Commercial Ops On Edaravone

Japanese mid-sized firm Mitsubishi Tanabe Pharma is building up its independent US commercial operations with a view to conducting the in-house marketing of new products, starting with an ALS therapy.

BioPharmaceutical Japan

Medical countermeasures drive pharma innovation: US officials

While the initial US response to the current Ebola crisis got off to a bumpy start, the fact there are two vaccines in efficacy trials in West Africa and several drugs in development against the deadly disease is proof the medical countermeasure (MCM) system is working, top officials insisted during testimony at a 26 February Capitol Hill hearing.

Cardiovascular Infectious Diseases

BARDA funds ZMapp-like Ebola drugs from Medicago, Fraunhofer

The Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and Human Services, has awarded contracts to biotech Medicago and nonprofit research and development firm Fraunhofer to make ZMapp-like Ebola drugs, the head of the agency revealed on 24 February.

Infectious Diseases Liberia
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
    • Large Molecule
    • Synthesis Technologies, Production Processes
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • Mitsubishi Chemical Holdings Corp.
  • Senior Management
  • Andy Sheldon, Pres. & CEO
    Pierre Labbé, VP, CFO
    Louis-Philippe Vézina, PhD, CSO
    Frederic Ors, VP, Bus. Dev.
  • Contact Info
  • Medicago Inc.
    Phone: (418) 658-9393
    1020, route de l'Église, Bureau 600
    Montreal, G1V 3V9